Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Dermatologic 1

Conditions

Breast Neoplasms 84Colorectal Neoplasms 42Rectal Neoplasms 40Carcinoma, Non-Small-Cell Lung 27Esophageal Neoplasms 24Esophageal Squamous Cell Carcinoma 23Stomach Neoplasms 19Lung Neoplasms 19Squamous Cell Carcinoma of Head and Neck 17Colonic Neoplasms 17Sarcoma 15Pancreatic Neoplasms 15Adenocarcinoma Of Esophagus 15Prostatic Neoplasms 13Neoplasm Metastasis 13Neoplasms 12Head and Neck Neoplasms 12Ovarian Neoplasms 11Carcinoma, Hepatocellular 11Inflammatory Breast Neoplasms 9Uterine Cervical Neoplasms 8Urinary Bladder Neoplasms 8Osteosarcoma 8Fallopian Tube Neoplasms 8Central Nervous System Neoplasms 8Carcinoma, Intraductal, Noninfiltrating 8Kidney Neoplasms 7Multiple Myeloma 6Glioblastoma 6Carcinoma, Renal Cell 6

Interventions

Ipilimumab 29Nivolumab 23pembrolizumab 14incomplete Freund's adjuvant 10Cyclophosphamide 10Interleukin-2 9Melphalan 8CTLA-4 Antigen 8sargramostim 7Temozolomide 7MART-1 Antigen 7Dacarbazine 7tebentafusp 6Ranibizumab 6montanide ISA 51 5fludarabine phosphate 5fludarabine 5Sunitinib 5Radiosurgery 5Carboplatin 5Bevacizumab 5aldesleukin 4aflibercept 4Magnetic Resonance Spectroscopy 4Granulocyte-Macrophage Colony-Stimulating Factor 4Blood Specimen Collection 4Biopsy 4trametinib 3sotrastaurin 3relatlimab 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Uveal Melanoma × Neoadjuvant Therapy × Clear all
NCT00324727 2021-06-21

Hepatic Arterial Infusion With Melphalan Compared With Standard Therapy in Treating Patients With Unresectable Liver Metastases Due to Melanoma

Delcath Systems Inc.

Phase 3 Completed
93 enrolled
Dermatologic

Uveal Melanoma, Melanoma, Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡